Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus tranexamic acid for bleeding reduction during rhinoplasty
IRCT20121229011923N6Phase 3Completed
- Sponsor
- Shoushtar Faculty of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of clonidine and tranexamic acid in intraoperative bleeding (3 arms), sponsored by Shoushtar Faculty of Medical Sciences. Primary endpoints: Amount of bleeding and Surgeon's vision. Started Feb 2019; status: completed.
02
Drugs
clonidinetranexamic acid
03
Conditions
intraoperative bleeding
Beyond the preview
Go deeper on IRCT20121229011923N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121229011923N6.